34,368 Perrigo Company plc $PRGO Shares Sold by State of Alaska Department of Revenue

State of Alaska Department of Revenue lowered its stake in shares of Perrigo Company plc (NYSE:PRGO) by 59.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 23,313 shares of the company’s stock after selling 34,368 shares during the period. State of Alaska Department of Revenue’s holdings in Perrigo were worth $344,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. First Trust Advisors LP grew its holdings in Perrigo by 125.5% during the first quarter. First Trust Advisors LP now owns 1,496,244 shares of the company’s stock valued at $16,070,000 after purchasing an additional 832,686 shares during the period. Y Intercept Hong Kong Ltd purchased a new stake in Perrigo in the first quarter worth $4,806,000. Diamond Hill Capital Management LLC Investment Advisor purchased a new stake in Perrigo in the second quarter worth $4,066,000. Sound Income Strategies LLC raised its stake in shares of Perrigo by 34.0% in the first quarter. Sound Income Strategies LLC now owns 1,525,384 shares of the company’s stock valued at $16,779,000 after buying an additional 387,027 shares during the period. Finally, Gamco Investors INC. ET AL raised its stake in shares of Perrigo by 29.7% in the first quarter. Gamco Investors INC. ET AL now owns 1,397,866 shares of the company’s stock valued at $15,013,000 after buying an additional 320,081 shares during the period. Institutional investors own 95.91% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on PRGO shares. Wall Street Zen cut Perrigo from a “strong-buy” rating to a “buy” rating in a research report on Sunday, September 27th. Weiss Ratings raised Perrigo from a “sell (d-)” rating to a “sell (d)” rating in a report on Thursday, August 6th. One equities research analyst has rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $17.50.

Perrigo Stock Performance

NYSE PRGO opened at $15.83 on Tuesday. The company’s 50 day moving average is $14.62 and its 200-day moving average is $12.46. Perrigo Company plc has a 12-month low of $9.23 and a 12-month high of $22.01. The company has a quick ratio of 1.32, a current ratio of 2.32 and a debt-to-equity ratio of 1.31. The firm has a market cap of $2.20 billion, a P/E ratio of -1.27, a price-to-earnings-growth ratio of 1.84 and a beta of 0.69.

Perrigo (NYSE:PRGO) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.50 EPS for the quarter, beating analysts’ consensus estimates of $0.39 by $0.11. Perrigo had a negative net margin of 41.85% and a positive return on equity of 11.25%. The company had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.02 billion. During the same period in the prior year, the company posted ($0.06) EPS. Perrigo’s revenue was down 3.1% compared to the same quarter last year. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. Sell-side analysts predict that Perrigo Company plc will post 2.17 earnings per share for the current year.

Perrigo Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Friday, August 28th were given a dividend of $0.29 per share. The ex-dividend date was Friday, August 28th. This represents a $1.16 annualized dividend and a dividend yield of 7.3%. Perrigo’s dividend payout ratio is currently -9.27%.

Perrigo Company Profile

Perrigo Company plc is a global consumer self-care company that develops, manufactures and markets over-the-counter health products, wellness products and personal care items. Its portfolio includes products for allergy, pain relief, digestive health, skin care, smoking cessation, women’s health and other everyday health needs, along with vitamins, nutritional supplements and infant nutrition products.

Perrigo supplies products under its own brands, acquired brands and retailer-owned private-label labels.